ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

RYTM Rhythm Pharmaceuticals Inc

39,76
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:05
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Rhythm Pharmaceuticals Inc RYTM NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 39,76 10:00:05
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
39,76
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202400:30GLOBERhythm Pharmaceuticals Announces Publication of Results from..
24/4/202422:01GLOBERhythm Pharmaceuticals to Report First Quarter 2024..
16/4/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
01/4/202414:00GLOBERhythm Pharmaceuticals Secures $150 Million in Convertible..
25/3/202413:00GLOBERhythm Pharmaceuticals Announces First Patient Dosed in..
11/3/202421:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
06/3/202422:01GLOBERhythm Pharmaceuticals Announces Participation at Upcoming..
29/2/202422:58EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202422:46EDGAR2Form 8-K - Current report
29/2/202422:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202422:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202413:01EDGAR2Form 8-K - Current report
22/2/202413:01GLOBERhythm Pharmaceuticals Announces Clinical Development Plan..
22/2/202413:00GLOBERhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial..
22/2/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:19EDGAR2Form 144 - Report of proposed sale of securities
08/2/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
07/2/202414:00GLOBERhythm Pharmaceuticals Announces Positive Reimbursement..
06/2/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202414:00GLOBERhythm Pharmaceuticals to Report Fourth Quarter and Full..
12/1/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
04/1/202413:15EDGAR2Form 8-K - Current report
04/1/202413:00EDGAR2Form 8-K - Current report
04/1/202413:00GLOBERhythm Pharmaceuticals and LG Chem Life Sciences Enter..
04/1/202412:58GLOBERhythm Pharmaceuticals Announces Completion of Screening for..
29/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:22EDGAR2Form 144 - Report of proposed sale of securities
18/12/202322:16EDGAR2Form 8-K - Current report
15/12/202322:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
13/12/202313:00GLOBERhythm Pharmaceuticals Sponsors Second Annual International..
06/12/202322:30EDGAR2Form 8-K - Current report
06/12/202313:00GLOBERhythm Pharmaceuticals Announces Updates on MC4R Pathway..
16/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
09/11/202322:14EDGAR2Form 144 - Report of proposed sale of securities
08/11/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:14EDGAR2Form 144 - Report of proposed sale of securities
08/11/202300:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

Delayed Upgrade Clock